Cory Robinson

Title: Cory Robinson: Innovator in Particle Technology

Introduction

Cory Robinson is a notable inventor based in Cambridge, MA (US), recognized for his contributions to the field of particle technology. With a total of 4 patents, Robinson has made significant strides in developing methods for the preparation of particles that include therapeutic and diagnostic agents.

Latest Patents

Robinson's latest patents focus on innovative methods for forming particles. One of his key inventions involves the preparation of particles that can encapsulate various agents, such as therapeutic or diagnostic substances. This process allows for the creation of droplets from a first liquid, which can then be solidified by removing the liquid through dispersal in a second liquid or evaporation. This method preserves the structure and activity of the agents, enhancing their stability for long-term storage without significant loss of efficacy. Additionally, these particles can be utilized in various applications, including pharmaceutical compositions, suspensions, and topical formulations.

Another significant patent involves the use of electrospray techniques to create particles that enable high concentrations of therapeutic or diagnostic agents to be delivered at low viscosity. This innovation not only improves the delivery of these agents but also contributes to their stability, making them suitable for a range of applications.

Career Highlights

Cory Robinson is currently employed at Elektrofi, Inc., where he continues to advance his research and development in particle technology. His work has positioned him as a key player in the field, contributing to the development of innovative solutions that address critical needs in pharmaceuticals and diagnostics.

Collaborations

Robinson collaborates with talented individuals such as Chase Spenser Coffman and Paul Brown, enhancing the innovative capacity of his projects and contributing to the success of their collective endeavors.

Conclusion

Cory Robinson's work in particle technology exemplifies the impact of innovation in the pharmaceutical and diagnostic fields. His patents reflect a commitment to enhancing the stability and delivery of therapeutic agents, paving the way for advancements in medical applications.